-
1
المؤلفون: M Carrasco Gomariz, N Martinez Casanova, M Lopez Martinez, A Cahue Urrutia, A Madrid Paredes, S Guijarro Herrera
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: medicine.medical_specialty, Deprescriptions, business.industry, Psychological intervention, Heartburn, Discontinuation, Clinical pharmacy, Regimen, Intervention (counseling), medicine, Deprescribing, medicine.symptom, Intensive care medicine, business, Section 4: Clinical pharmacy services
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c1c5c8ee29039af717e7f855f516479
https://doi.org/10.1136/ejhpharm-2018-eahpconf.97 -
2
المؤلفون: M Alami Chentoufi, A Tebaa, I Talibi, R Soulaymani, M Benabbes
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: Drug, medicine.medical_specialty, business.industry, Incidence (epidemiology), media_common.quotation_subject, Retrospective cohort study, medicine.disease, Rash, Dermatology, Pharmacovigilance, medicine, Prednisolone, Eosinophilia, Section 5: Patient safety and quality assurance, medicine.symptom, business, Adverse drug reaction, medicine.drug, media_common
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae0351f982b54ca6ecbbc7359a06176
https://doi.org/10.1136/ejhpharm-2018-eahpconf.484 -
3
المؤلفون: M Sanjurjo Sáez, Pernia López, FJ Garcia Moreno
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: Amifampridine, medicine.drug_class, business.industry, Congenital myasthenic syndrome, medicine.disease, Hypotonia, Neostigmine, Respiratory failure, Pyridostigmine, Anesthesia, medicine, Paralysis, Anticholinergic, medicine.symptom, business, Section 3: Production and compounding, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646800739a2575a8942ade29dd6df32a
https://doi.org/10.1136/ejhpharm-2018-eahpconf.79 -
4
المؤلفون: A Lucena Campillo, S Ramirez Cruz, AL Salcedo Mingoarranz, L Corregidor Luna, L de Agustin Sierra, A Puebla Villaescusa
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: medicine.medical_specialty, Nausea, business.industry, Cancer, Ipilimumab, medicine.disease, Gastroenterology, Rash, Clinical trial, Internal medicine, medicine, Section 5: Patient safety and quality assurance, Nivolumab, medicine.symptom, Lung cancer, Adverse effect, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6573ed5d13b4d35f4d7a34b01ef55923
https://doi.org/10.1136/ejhpharm-2018-eahpconf.413 -
5
المؤلفون: Paloma L Martin-Moreno, Francisco Guillén-Grima, José Ignacio Herrero, M Serrano, Mirian Fernández-Alonso, MA Garcia-Del-Barrio, Gabriel Reina, Gregorio Rábago
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Cmv infections, Congenital cytomegalovirus infection, virus diseases, Cancer, medicine.disease, Asymptomatic, Internal medicine, Toxicity, medicine, medicine.symptom, Serostatus, Solid organ transplantation, business, Section 4: Clinical pharmacy services, Transplant type
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0579b79159cf061990f854f5627e2694
https://doi.org/10.1136/ejhpharm-2018-eahpconf.188 -
6
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: medicine.medical_specialty, CD52, Nausea, business.industry, Multiple sclerosis, Incidence (epidemiology), Phases of clinical research, medicine.disease, Rash, Natalizumab, Internal medicine, medicine, Alemtuzumab, Section 5: Patient safety and quality assurance, medicine.symptom, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcdd34927bd8368fadf8d7d813c94da8
https://doi.org/10.1136/ejhpharm-2018-eahpconf.434 -
7
المؤلفون: G. Hempel, K. Ilting-Reuke, P. Ohrmann, A. Roos, T. Duning
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: Polypharmacy, medicine.medical_specialty, business.industry, medicine.drug_class, Montreal Cognitive Assessment, law.invention, Clinical pharmacy, Randomized controlled trial, law, Acute care, mental disorders, Emergency medicine, Anticholinergic, Medicine, Delirium, medicine.symptom, business, Adverse effect, Section 4: Clinical pharmacy services
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::844e05a41c21f9f45707444efa38634b
https://doi.org/10.1136/ejhpharm-2018-eahpconf.268 -
8
المؤلفون: A García Márquez, ALloret Llorca, I Muñoz García, IG Pérez Pérez, B Fernández-Lobato, R Gutiérrez Cívicos, S Nuñez Bracamonte, LM Escondrillas Gómez, E Conesa Nicolás, C González Pérez-Crespo, C Juez Santamaría
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: business.industry, Pharmacy, medicine.disease, Section 2: Selection, procurement and distribution, Health personnel, medicine, Support system, Business, Medical emergency, Quality of care, medicine.symptom, Training programme, Whole Care, Confusion
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b834df6bfc232754752b136c940efa
https://doi.org/10.1136/ejhpharm-2018-eahpconf.41 -
9
المؤلفون: B Laszloffy, M Hoppel, D Haider, J Faschang
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: medicine.medical_specialty, Deprescriptions, business.industry, Peptic, Psychological intervention, Pharmacist, Heartburn, Guideline, Indigestion, Medicine, medicine.symptom, Medical prescription, business, Intensive care medicine, Section 4: Clinical pharmacy services
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b05d2f05bb576fd841d15561948d4711
https://doi.org/10.1136/ejhpharm-2018-eahpconf.92 -
10
المؤلفون: M Benabbes, A Tebaa, I Talibi, M Alami Chentoufi, R Soulaymani
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: Drug, medicine.medical_specialty, Medical treatment, business.industry, media_common.quotation_subject, Lupus nephritis, medicine.disease, Hyperpigmentation, Dermatology, Chloroquine, Skin hyperpigmentation, medicine, Section 5: Patient safety and quality assurance, Enalapril, medicine.symptom, Adverse effect, business, medicine.drug, media_common
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac9f888417b91d8b174b33d759b30f8
https://doi.org/10.1136/ejhpharm-2018-eahpconf.486